Name | SR-4370 |
---|
Description | SR-4370 is an inhibitor of HDAC, with IC50s of 0.13 μM, 0.58 μM, 0.006 μM, 2.3 μM, and 3.4 μM for HDAC1, HDAC2, HDAC3, HDAC8, and HDAC6, respectively. |
---|---|
Related Catalog | |
Target |
HDAC3:6 nM (IC50) HDAC1:130 nM (IC50) HDAC2:580 nM (IC50) HDAC8:2300 nM (IC50) HDAC6:3400 nM (IC50) |
In Vitro | SR-4370 is an inhibitor of HDAC, with IC50s of 0.13 μM, 0.58 μM, 0.006 μM, 2.3 μM, and 3.4 μM for HDAC1, HDAC2, HDAC3, HDAC8, and HDAC6, respectively. SR-4370 is cytotoxic to the breast cancer cells (MDA-MB-231), with an IC50 of 12.6 μM[1]. |
References |
[1]. LIAO, Daiqing, et al. HDAC INHIBITOR COMPOUNDS AND METHODS OF TREATMENT. WO 2015153516 A1. |
Molecular Formula | C17H18F2N2O |
---|---|
Molecular Weight | 304.33 |
Storage condition | 2-8℃ |